Literature DB >> 25796346

Why the honey badger don't care: Convergent evolution of venom-targeted nicotinic acetylcholine receptors in mammals that survive venomous snake bites.

Danielle H Drabeck1, Antony M Dean2, Sharon A Jansa3.   

Abstract

Honey badgers (Mellivora capensis) prey upon and survive bites from venomous snakes (Family: Elapidae), but the molecular basis of their venom resistance is unknown. The muscular nicotinic cholinergic receptor (nAChR), targeted by snake α-neurotoxins, has evolved in some venom-resistant mammals to no longer bind these toxins. Through phylogenetic analysis of mammalian nAChR sequences, we show that honey badgers, hedgehogs, and pigs have independently acquired functionally equivalent amino acid replacements in the toxin-binding site of this receptor. These convergent amino acid changes impede toxin binding by introducing a positively charged amino acid in place of an uncharged aromatic residue. In venom-resistant mongooses, different replacements at these same sites are glycosylated, which is thought to disrupt binding through steric effects. Thus, it appears that resistance to snake venom α-neurotoxin has evolved at least four times among mammals through two distinct biochemical mechanisms operating at the same sites on the same receptor.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Convergent evolution; Honey badger; Mellivora capensis; Nicotinic acetylcholine receptor; Venom resistance

Mesh:

Substances:

Year:  2015        PMID: 25796346     DOI: 10.1016/j.toxicon.2015.03.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  15 in total

1.  Widespread convergence in toxin resistance by predictable molecular evolution.

Authors:  Beata Ujvari; Nicholas R Casewell; Kartik Sunagar; Kevin Arbuckle; Wolfgang Wüster; Nathan Lo; Denis O'Meally; Christa Beckmann; Glenn F King; Evelyne Deplazes; Thomas Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 2.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

3.  The roles of balancing selection and recombination in the evolution of rattlesnake venom.

Authors:  Drew R Schield; Blair W Perry; Richard H Adams; Matthew L Holding; Zachary L Nikolakis; Siddharth S Gopalan; Cara F Smith; Joshua M Parker; Jesse M Meik; Michael DeGiorgio; Stephen P Mackessy; Todd A Castoe
Journal:  Nat Ecol Evol       Date:  2022-07-18       Impact factor: 19.100

4.  Rattlesnake envenomation in 2 Visayan warty pigs.

Authors:  Eileen E Henderson; Cynthia K Stadler; Robert H Poppenga; Javier Asin Ros; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2021-09-11       Impact factor: 1.569

5.  Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom Toxins.

Authors:  Md Mahfuzur Rahman; Jinfeng Teng; Brady T Worrell; Colleen M Noviello; Myeongseon Lee; Arthur Karlin; Michael H B Stowell; Ryan E Hibbs
Journal:  Neuron       Date:  2020-04-09       Impact factor: 17.173

6.  Electrostatic resistance to alpha-neurotoxins conferred by charge reversal mutations in nicotinic acetylcholine receptors.

Authors:  Richard J Harris; Bryan G Fry
Journal:  Proc Biol Sci       Date:  2021-01-13       Impact factor: 5.349

7.  Population Genomic Analysis of a Pitviper Reveals Microevolutionary Forces Underlying Venom Chemistry.

Authors:  Steven D Aird; Jigyasa Arora; Agneesh Barua; Lijun Qiu; Kouki Terada; Alexander S Mikheyev
Journal:  Genome Biol Evol       Date:  2017-10-01       Impact factor: 3.416

8.  Epidemiology, Clinical Features, and Management of Texas Coral Snake (Micrurus tener) Envenomations Reported to the North American Snakebite Registry.

Authors:  Spencer Greene; Anne-Michelle Ruha; Sharan Campleman; Jeffrey Brent; Paul Wax
Journal:  J Med Toxicol       Date:  2020-08-14

9.  BoaγPLI from Boa constrictor Blood is a Broad-Spectrum Inhibitor of Venom PLA2 Pathophysiological Actions.

Authors:  Caroline Fabri Bittencourt Rodrigues; Christina N Zdenek; Caroline Serino-Silva; Karen de Morais-Zani; Kathleen Fernandes Grego; Melisa Bénard-Valle; Edgar Neri-Castro; Alejandro Alagón; Anita Mitico Tanaka-Azevedo; Bryan Grieg Fry
Journal:  J Chem Ecol       Date:  2021-06-24       Impact factor: 2.626

10.  Overlooked Short Toxin-Like Proteins: A Shortcut to Drug Design.

Authors:  Michal Linial; Nadav Rappoport; Dan Ofer
Journal:  Toxins (Basel)       Date:  2017-10-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.